Revisiting the central aortopulmonary shunt procedure.
Cardiac
congenital heart disease
pulmonary artery
pulmonary vein
shunt
Journal
Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
30
09
2022
accepted:
28
02
2023
medline:
24
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
In this study, we present our experience with the central aortopulmonary shunt technique with interposing a polytetrafluoroethylene graft between main pulmonary artery (end-to-end) and the ascending aorta (side-to-side) in a variety of cyanotic congenital heart defects. Between January 2019 and June 2022, a total of 10 patients (6 males, 4 females; mean age: 4.3±2.8 months; range, 5 days to 10 months) with hypoplastic central pulmonary arteries who underwent central aortopulmonary shunt procedure were retrospectively analyzed. Demographic characteristics, preoperative, operative, and postoperative data of the patients were recorded. The Nakata indices of the patients were also noted before the procedure, as well as before the second stage of palliation or definitive repair. Four (40%) patients were operated as the first-step palliation for univentricular circulation. Six (60%) patients had well-developed ventricles and were palliated to be treated with total correction. The median follow-up after the procedure was 12 (range, 8 to 16) months. The mean systemic arterial saturation level at room air was 89.3±2.9% during follow-up. No mortality was observed in any patient. A central aortopulmonary shunt procedure provides a reliable antegrade blood flow with a relatively non-challenging surgical technique that offers sufficient growth for the hypoplastic and confluent central pulmonary arteries with a very low risk of shunt thrombosis and overflow.
Sections du résumé
Background
UNASSIGNED
In this study, we present our experience with the central aortopulmonary shunt technique with interposing a polytetrafluoroethylene graft between main pulmonary artery (end-to-end) and the ascending aorta (side-to-side) in a variety of cyanotic congenital heart defects.
Methods
UNASSIGNED
Between January 2019 and June 2022, a total of 10 patients (6 males, 4 females; mean age: 4.3±2.8 months; range, 5 days to 10 months) with hypoplastic central pulmonary arteries who underwent central aortopulmonary shunt procedure were retrospectively analyzed. Demographic characteristics, preoperative, operative, and postoperative data of the patients were recorded. The Nakata indices of the patients were also noted before the procedure, as well as before the second stage of palliation or definitive repair.
Results
UNASSIGNED
Four (40%) patients were operated as the first-step palliation for univentricular circulation. Six (60%) patients had well-developed ventricles and were palliated to be treated with total correction. The median follow-up after the procedure was 12 (range, 8 to 16) months. The mean systemic arterial saturation level at room air was 89.3±2.9% during follow-up. No mortality was observed in any patient.
Conclusion
UNASSIGNED
A central aortopulmonary shunt procedure provides a reliable antegrade blood flow with a relatively non-challenging surgical technique that offers sufficient growth for the hypoplastic and confluent central pulmonary arteries with a very low risk of shunt thrombosis and overflow.
Identifiants
pubmed: 37484647
doi: 10.5606/tgkdc.dergisi.2023.24247
pmc: PMC10357854
doi:
Types de publication
Journal Article
Langues
eng
Pagination
207-214Informations de copyright
Copyright © 2023, Turkish Society of Cardiovascular Surgery.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
Ann Thorac Surg. 2008 Jun;85(6):2079-83; discussion 2083-4
pubmed: 18498824
Catheter Cardiovasc Interv. 2015 Aug;86(2):249-57
pubmed: 25855154
J Thorac Cardiovasc Surg. 2014 Feb;147(2):672-7
pubmed: 24252942
World J Pediatr Congenit Heart Surg. 2015 Jan;6(1):67-74
pubmed: 25548346
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E233-43
pubmed: 23420699
Eur J Cardiothorac Surg. 2013 Dec;44(6):1096-102
pubmed: 23539419
Congenit Heart Dis. 2012 Nov-Dec;7(6):526-33
pubmed: 22548982
Multimed Man Cardiothorac Surg. 2014 Jun 12;2014:
pubmed: 24941030
J Card Surg. 2014 Jul;29(4):537-41
pubmed: 24750206
J Am Coll Surg. 2013 Apr;216(4):699-704; discussion 704-6
pubmed: 23415555
J Biomech. 2017 Jan 4;50:166-171
pubmed: 27866675
Ann Thorac Surg. 1998 Feb;65(2):515-6
pubmed: 9485256
Ann Thorac Surg. 1991 Nov;52(5):1132-7
pubmed: 1953135
JACC Cardiovasc Interv. 2015 Oct;8(12):1626-32
pubmed: 26386761
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):194
pubmed: 18381364
Acta Cardiol. 2017 Apr;72(2):142-148
pubmed: 28597797
J Thorac Cardiovasc Surg. 2002 Jun;123(6):1147-54
pubmed: 12063462
Ann Thorac Surg. 2011 Aug;92(2):642-51; discussion 651-2
pubmed: 21550583
Surgery. 1962 Oct;52:675-8
pubmed: 14039246
Thorax. 1955 Dec;10(4):348-50
pubmed: 13281834
J Thorac Cardiovasc Surg. 2011 Jul;142(1):106-12
pubmed: 21272898
J Thorac Cardiovasc Surg. 1987 May;93(5):767-74
pubmed: 3573789
Thorac Cardiovasc Surg. 2014 Apr;62(3):211-5
pubmed: 24065601
Ann Thorac Surg. 2011 Oct;92(4):1476-82
pubmed: 21958799
Circulation. 1974 Mar;49(3):508-11
pubmed: 4813185
Br Heart J. 1992 Mar;67(3):240-5
pubmed: 1372815
J Thorac Cardiovasc Surg. 2019 Oct;158(4):1144-1153.e6
pubmed: 31350024
Ann Thorac Surg. 1996 Jul;62(1):161-8
pubmed: 8678637